跳至主要内容
临床试验/NCT01244100
NCT01244100已完成1 期

Food-Effect Pharmacokinetic Study of PL2200

PLx Pharma1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Effect of food by ratio of least-squares means (LSM) of the pharmacokinetic (PK) parameter of AUC0-t of the primary metabolite, salicylic acid, in the fed state versus the fasted state.

研究概览

简要总结

This trial is a food-effect study to assess fasted versus fed pharmacokinetics of PL2200.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy normal male and female volunteers between 21 and 65 years of age.

排除标准

  • Abnormal findings on physical examination or clinical laboratories, or significant medical history.
  • Subject with hypersensitivity or contraindications to aspirin, ibuprofen, or other nonsteroidal anti-inflammatory drug (NSAID).

研究组 & 干预措施

PL2200

Experimental

干预措施: PL2200 fasted (Drug)

PL2200

Experimental

干预措施: PL2200 fed (Drug)

结局指标

主要结局

Effect of food by ratio of least-squares means (LSM) of the pharmacokinetic (PK) parameter of AUC0-t of the primary metabolite, salicylic acid, in the fed state versus the fasted state.

时间窗: 24 hours

Effect of food by ratio of least-squares means (LSM) of the PK parameter of AUC0-inf of the primary metabolite, salicylic acid, in the fed state versus the fasted state.

时间窗: 24 hours

Effect of food by ratio of least-squares means (LSM) of the PK parameter of Cmax of the primary metabolite, salicylic acid, in the fed state versus the fasted state.

时间窗: 24 hours

次要结局

未报告次要终点

研究者

发起方
PLx Pharma
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验